Mutation analysis of the MECP2 gene in patients of Slavic origin with Rett syndrome: novel mutations and polymorphisms

. 2007 ; 52 (4) : 342-348. [epub] 20070215

Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid17387578
Odkazy

PubMed 17387578
DOI 10.1007/s10038-007-0121-x
PII: 10.1007/s10038-007-0121-x
Knihovny.cz E-zdroje

Rett syndrome (RTT), an X-linked dominant neurodevelopmental disorder in females, is caused mainly by de novo mutations in the methyl-CpG-binding protein 2 gene (MECP2). Here we report mutation analysis of the MECP2 gene in 87 patients with RTT from the Czech and Slovak Republics, and Ukraine. The patients, all girls, with classical RTT were investigated for mutations using bi-directional DNA sequencing and conformation sensitive gel electrophoresis analysis of the coding sequence and exon/intron boundaries of the MECP2 gene. Restriction fragment length polymorphism analysis was performed to confirm the mutations that cause the creation or abolition of the restriction site. Mutation-negative cases were subsequently examined by multiple ligation-dependent probe amplification (MLPA) to identify large deletions. Mutation screening revealed 31 different mutations in 68 patients and 12 non-pathogenic polymorphisms. Six mutations have not been previously published: two point mutations (323T>A, 904C>T), three deletions (189_190delGA, 816_832del17, 1069delAGC) and one deletion/inversion (1063_1236del174;1189_1231inv43). MLPA analysis revealed large deletions in two patients. The detection rate was 78.16%. Our results confirm the high frequency of MECP2 mutations in females with RTT and provide data concerning the mutation heterogeneity in the Slavic population.

Zobrazit více v PubMed

Nature. 1998 May 28;393(6683):386-9 PubMed

Nat Genet. 1998 Jun;19(2):187-91 PubMed

Brain Dev. 2001 Jul;23(4):208-11 PubMed

Am J Hum Genet. 2004 Dec;75(6):1149-54 PubMed

Eur J Hum Genet. 2000 May;8(5):325-30 PubMed

Proc Natl Acad Sci U S A. 2005 Dec 6;102(49):17551-8 PubMed

Curr Opin Genet Dev. 2000 Jun;10(3):275-9 PubMed

Hum Mol Genet. 2000 Apr 12;9(7):1119-29 PubMed

Biochemistry. 2000 Jun 20;39(24):7100-6 PubMed

Ment Retard Dev Disabil Res Rev. 2002;8(2):99-105 PubMed

Hum Mutat. 2001 Mar;17(3):183-90 PubMed

Wien Med Wochenschr. 1966 Sep 10;116(37):723-6 PubMed

Eur J Hum Genet. 2005 Aug;13(8):921-7 PubMed

Am J Hum Genet. 2000 Dec;67(6):1428-36 PubMed

Am J Med Genet B Neuropsychiatr Genet. 2004 Jul 1;128B(1):50-3 PubMed

J Med Genet. 2005 Feb;42(2):e15 PubMed

Am J Med Genet A. 2003 Mar 1;117A(2):184-7 PubMed

Am J Med Genet. 2000 Summer;97(2):147-52 PubMed

Hum Genet. 2001 Jan;108(1):43-50 PubMed

Eur Child Adolesc Psychiatry. 1997;6 Suppl 1:14-7 PubMed

Neuropediatrics. 1995 Apr;26(2):62 PubMed

Hum Mol Genet. 2005 Jul 15;14(14):1935-46 PubMed

Neurology. 2001 Jun 12;56(11):1486-95 PubMed

Nat Genet. 1999 Oct;23(2):185-8 PubMed

Eur Child Adolesc Psychiatry. 2001 Jun;10(2):117-21 PubMed

Hum Mol Genet. 2001 Apr 15;10(9):941-6 PubMed

Ann Neurol. 1983 Oct;14(4):471-9 PubMed

Am J Hum Genet. 2004 Dec;75(6):1079-93 PubMed

Hum Mol Genet. 2000 May 22;9(9):1369-75 PubMed

J Child Neurol. 2002 Jan;17(1):20-4 PubMed

Eur J Hum Genet. 2005 Jan;13(1):124-6 PubMed

Am J Hum Genet. 1999 Dec;65(6):1520-9 PubMed

Nat Genet. 2004 Apr;36(4):339-41 PubMed

Hum Mutat. 2004 Mar;23(3):234-44 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...